Authors:
Erman, MK
Erwin, CW
Gengo, FM
Jamieson, AO
Lemmi, H
Mahowald, MW
Regestein, QR
Roth, T
Roth-Schecher, B
Scharf, MB
Vogel, GW
Walsh, JK
Ware, JC
Citation: Mk. Erman et al., Comparative efficacy of zolpidem and temazepam in transient insomnia, HUM PSYCHOP, 16(2), 2001, pp. 169-176
Citation: T. Roth et R. Laenen, Absorption of free carriers in diamond determined from the visible to the mid-infrared by femtosecond two-photon absorption spectroscopy, OPT COMMUN, 189(4-6), 2001, pp. 289-296
Citation: R. Laenen et T. Roth, Generation of solvated electrons in neat water: new results from femtosecond spectroscopy, J MOL STRUC, 598(1), 2001, pp. 37-43
Authors:
Easmon, J
Purstinger, G
Heinisch, G
Roth, T
Fiebig, HH
Holzer, W
Jager, W
Jenny, M
Hofmann, J
Citation: J. Easmon et al., Synthesis, cytotoxicity, and antitumor activity of copper(II) and iron(II)complexes of N-4-azabicyclo[3.2.2]nonane thiosemicarbazones derived from acyl diazines, J MED CHEM, 44(13), 2001, pp. 2164-2171
Authors:
Easmon, J
Puerstinger, G
Roth, T
Fiebig, HH
Jenny, M
Jaeger, W
Heinisch, G
Hofmann, J
Citation: J. Easmon et al., 2-benzoxazolyl and 2-benzimidazolyl hydrazones derived from 2-acetylpyridine: A novel class of antitumor agents, INT J CANC, 94(1), 2001, pp. 89-96
Authors:
Skinner, P
Kopecky, L
Seburg, S
Roth, T
Eich, J
Lewis, NM
Citation: P. Skinner et al., Development of a medical nutrition therapy protocol for female collegiate athletes, J AM DIET A, 101(8), 2001, pp. 914-917
Authors:
Kratz, F
Roth, T
Fichiner, I
Schumacher, P
Fiebig, HH
Unger, C
Citation: F. Kratz et al., In vitro and in vivo efficacy of acid-sensitive transferrin and albumin doxorubicin conjugates in a human xenograft panel and in the MDA-MB-435 mammacarcinoma model, J DRUG TAR, 8(5), 2000, pp. 305-318
Citation: G. Rubino et al., Therapist empathy and depth of interpretation in response to potential alliance ruptures: The role of therapist and patient attachment styles, PSYCHOTH RE, 10(4), 2000, pp. 408-420
Citation: Cl. Drake et al., Dose-response effects of zaleplon as compared with triazolam (0.25 mg) andplacebo in chronic primary insomnia, HUM PSYCHOP, 15(8), 2000, pp. 595-604